Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Therapeutic potential of cannabis in pain medicine.

Hosking RD, Zajicek JP.

Br J Anaesth. 2008 Jul;101(1):59-68. doi: 10.1093/bja/aen119. Review.

PMID:
18515270
2.

Therapeutic potential of cannabinoids in CNS disease.

Croxford JL.

CNS Drugs. 2003;17(3):179-202. Review.

PMID:
12617697
3.

Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy.

Rice AS, Farquhar-Smith WP, Nagy I.

Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):243-56. Review.

PMID:
12052040
4.

Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.

Smith PF.

Curr Opin Investig Drugs. 2002 Jun;3(6):859-64. Review.

PMID:
12137404
5.

Cannabis and the brain.

Iversen L.

Brain. 2003 Jun;126(Pt 6):1252-70. Review.

PMID:
12764049
6.

Cannabis and cannabinoids: pharmacology and rationale for clinical use.

Pertwee RG.

Forsch Komplementarmed. 1999 Oct;6 Suppl 3:12-5. Review.

PMID:
10575283
7.

Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.

Burns TL, Ineck JR.

Ann Pharmacother. 2006 Feb;40(2):251-60. Review.

PMID:
16449552
8.

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.

Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R.

Trends Pharmacol Sci. 2009 Oct;30(10):515-27. doi: 10.1016/j.tips.2009.07.006. Review. Erratum in: Trends Pharmacol Sci. 2009 Dec;30(12):609.

PMID:
19729208
9.

[The pharmacology of cannabinoid derivatives: are there applications to treatment of pain?].

Beaulieu P, Rice AS.

Ann Fr Anesth Reanim. 2002 Jun;21(6):493-508. Review. French.

PMID:
12134594
10.

Therapeutic potential of cannabinoid receptor agonists as analgesic agents.

Fox A, Bevan S.

Expert Opin Investig Drugs. 2005 Jun;14(6):695-703. Review.

PMID:
16004597
11.

Cannabinoids and multiple sclerosis.

Pertwee RG.

Pharmacol Ther. 2002 Aug;95(2):165-74. Review.

PMID:
12182963
12.

Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?

Oesch S, Gertsch J.

J Pharm Pharmacol. 2009 Jul;61(7):839-53. doi: 10.1211/jpp/61.07.0002. Review.

PMID:
19589225
13.

Cannabinoid transmission and pain perception.

Martin BR, Lichtman AH.

Neurobiol Dis. 1998 Dec;5(6 Pt B):447-61. Review.

PMID:
9974177
14.

Targeting cannabinoid agonists for inflammatory and neuropathic pain.

Cheng Y, Hitchcock SA.

Expert Opin Investig Drugs. 2007 Jul;16(7):951-65. Review.

PMID:
17594182
15.

Pharmacological actions and therapeutic uses of cannabis and cannabinoids.

Kumar RN, Chambers WA, Pertwee RG.

Anaesthesia. 2001 Nov;56(11):1059-68. Review.

16.

Towards cannabis and cannabinoid treatment of multiple sclerosis.

Croxford JL, Miller SD.

Drugs Today (Barc). 2004 Aug;40(8):663-76. Review.

PMID:
15510238
17.

CB receptor ligands from plants.

Woelkart K, Salo-Ahen OM, Bauer R.

Curr Top Med Chem. 2008;8(3):173-86. Review.

PMID:
18289087
18.

The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.

McCarberg BH, Barkin RL.

Am J Ther. 2007 Sep-Oct;14(5):475-83. Review.

PMID:
17890938
19.

Pharmacology and toxicology of Cannabis derivatives and endocannabinoid agonists.

Gerra G, Zaimovic A, Gerra ML, Ciccocioppo R, Cippitelli A, Serpelloni G, Somaini L.

Recent Pat CNS Drug Discov. 2010 Jan;5(1):46-52. Review.

PMID:
19832688
20.

Implication of cannabinoids in neurological diseases.

Alsasua del Valle A.

Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):579-91. Review.

PMID:
16699878

Supplemental Content

Support Center